Clinical studies recruiting near Angers

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Generation of an Artificial Intelligence Algorithm Based on the Analysis of Melanoma Peri-scar Dermatoheliosis, as a Pre
Phase N/A · Angers University Hospital · Nantes University Hospital · NCT05856565 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Institut de Cancérologie de l'Ouest · Eli Lilly and Company · NCT07218380 Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Phase 3 · CHU ANgers · Fondation Hôpital Saint-Joseph · NCT05674994 Autosomal Dominant Spinocerebellar Ataxias and Social Cognition
NA · CHU Angers · University Hospital, Angers · NCT07099651 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Institut de Cancérologie de l'Ouest · Pfizer · NCT07028853 Program of Physical Activity, Nutrition and Supportive to Improve the Quality of Life of Breast Cancer Survivors
NA · Angers · Siel Bleu · NCT05658341 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Institut de Cancérologie de l'Ouest ( Site 1316) · Merck Sharp & Dohme LLC · NCT06393374 EVASION: Effect of VisuAl Stimulation on attentION
NA · Angers University Hospital · University Hospital, Angers · NCT05791994 Randomized Phase III Trial Testing Maintenance Olaparib Versus Observation After Adjuvant Chemoradiation for p53abn Endo
Phase 3 · Institut Cancerologie de L'Ouest-Angers · Gustave Roussy, Cancer Campus, Grand Paris · NCT06712472 French Colorectal ESD Cohort in Experts Centers
Phase N/A · Clinique de l'Anjou · University Hospital, Limoges · NCT04592003 A Pilot Study to Assess the Feasibility and Acceptability of Newborn Screening Using in Silico Panel-based Solo Genome S
Phase N/A · CHU d'Angers · Centre Hospitalier Universitaire Dijon · NCT06875089 Non-Invasive Ventilation Versus High-flow Nasal Oxygen in Intensive Care Units
NA · Angers University Hospital · Poitiers University Hospital · NCT05686850 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · CHU Angers · Hoffmann-La Roche · NCT06793215 Identification of Genetic Variants Associated With Unexpected Infant Death Syndrome
Phase N/A · CHU Angers · Nantes University Hospital · NCT06244433 Role of High-Throughput Whole Genome Sequencing for the Diagnosis and Care of Atypical Diabetes
NA · University Hospital · Institut National de la Santé Et de la Recherche Médicale, F · NCT06570278 Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation
Phase 2 · Service Maladies du sang CHU Angers · University Hospital, Clermont-Ferrand · NCT04935684 Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System Tumors
Phase 1/Phase 2 · Institut de Cancérologie de l'Ouest · Centre Leon Berard · NCT07243470 Transplantation After Complete Response In Patients With T-cell Lymphoma
NA · Chu D'Angers · Hospices Civils de Lyon · NCT05444712 A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD
Phase 1/Phase 2 · Centre Hospitalier Universitaire dÁngers · Vico Therapeutics B. V. · NCT05822908 ProspEXPO : Study of the Associations Between Hepatocellular Carcinoma and Chemical and Psychosocial Environmental EXPOs
NA · Angers University Hospital · University Hospital, Angers · NCT07119957 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined
Phase 3 · Centre Hospitalier Universitaire Angers · Regeneron Pharmaceuticals · NCT06091865 A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Phase 2 · Institut de Cancerologie de l'Ouest- Angers · Fore Biotherapeutics · NCT05503797 Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More
Phase 2 · CHU Angers · Assistance Publique - Hôpitaux de Paris · NCT06646497 Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic C
Phase 2 · Institut de Cancérologie de l'Ouest · UNICANCER · NCT06245356 Identification of Factors Associated With Treatment Response in Patients With Polycythemia Vera, Essential Thrombocythem
Phase N/A · Chu Angers · University Hospital, Angers · NCT05440838 Validation of a Rapid Screening Tool for Anxiety-depressive Disorders in Children, Adolescents and Young Adults Treated
Phase N/A · CHU Angers · Centre Hospitalier Universitaire de Saint Etienne · NCT07117058 Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes After Assisted Reproductive Technology
Phase 3 · CHU Angers · University Hospital, Toulouse · NCT05625724 Post Traumatic Critical Complications: a Prospective Cohort Study (ATLANREA)
Phase N/A · Angers University Hospital · Nantes University Hospital · NCT02426255 A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · Institut de Cancérologie de l'Ouest ( Site 1101) · Merck Sharp & Dohme LLC · NCT06077760

Look up another city

Look up another condition